Articles from Levi & Korsinsky
Shareholders of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) saw the stock plunged roughly 50% on June 1, 2026, following disclosure of an FDA safety concerns related to the PRC2 inhibitor drug class. Those who lost money on FULC are encouraged to submit their information immediately. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
By Levi & Korsinsky · Via Business Wire · June 4, 2026
Investors in Planet Fitness, Inc. (NYSE: PLNT) suffered significant losses after the Company issued weaker-than-expected FY 2026 outlook, undermining management’s earlier projection of approximately 9%-10% EPS growth discussed by CFO Jay Stasz during the Company’s Q4 2025 earnings call. Shareholders who lost money on their Planet Fitness investment are encouraged to submit their information here. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
By Levi & Korsinsky · Via Business Wire · May 19, 2026
